BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 4725398)

  • 1. The histological response to a xenogeneic tumour in mice.
    Simpson E; Beverley PC
    Clin Exp Immunol; 1973 Jul; 14(3):443-55. PubMed ID: 4725398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial transplantation of Burkitt's tumor (EB3) cells in newborn Syrian hamsters and its facilitation by antilymphocyte serum.
    Adams RA; Foley GE; Frber S; Flowers A; Lazarus H; Hellerstein EE
    Cancer Res; 1970 Feb; 30(2):338-45. PubMed ID: 4917979
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of infant thymectomy and antilymphocyte serum on xenotransplantation of a human leukemia in the hamster.
    Merk LP; Adams RA
    Cancer Res; 1972 Jul; 32(7):1580-3. PubMed ID: 4503630
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in lymphoreticular tissues during growth of a murine adenocarcinoma. I. Histology and weight of lymph nodes, spleen, and thymus.
    Edwards AJ; Sumner MR; Rowland GF; Hurd CM
    J Natl Cancer Inst; 1971 Aug; 47(2):301-11. PubMed ID: 5559238
    [No Abstract]   [Full Text] [Related]  

  • 5. Depression of alloantigens in malignancy. Evidence for tumour susceptibility alloantigens and for possible self-reactivity of lymphoid cells active in the microcytotoxicity assay.
    Martin WJ; Esber E; Cotton WG; Rice JM
    Br J Cancer Suppl; 1973 Aug; 1():48-61. PubMed ID: 4804290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A direct relationship between immune competence and the subcutaneous growth rate of a malignant murine lung tumor.
    Yuhas JM; Pazmino NH; Proctor JO; Toya RE
    Cancer Res; 1974 Apr; 34(4):722-8. PubMed ID: 4360837
    [No Abstract]   [Full Text] [Related]  

  • 7. Transplantation of allogeneic tumours in rats treated with antilymphocyte serum.
    Kellen JA
    Oncology; 1973; 28(5):439-44. PubMed ID: 4770464
    [No Abstract]   [Full Text] [Related]  

  • 8. Orchidectomy and immune response.
    Castro JE
    Ann R Coll Surg Engl; 1976 Sep; 58(5):359-67. PubMed ID: 788619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trasylol (aprotinin) as an anti-tumour agent.
    Tweedie DJ; Thomson AW; Horne CH
    Biomedicine; 1978 Feb; 29(1):1-3. PubMed ID: 307409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation behavior of Hodgkin's-like reticulum cell neoplasms of strain SJL-J mice and results of tumor reinoculation.
    Murphy ED
    J Natl Cancer Inst; 1969 May; 42(5):797-807. PubMed ID: 4891489
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-mediated responses to tumour xenografts in mice.
    Simpson E; Beverley PC
    Int J Cancer; 1972 Mar; 9(2):299-304. PubMed ID: 5041608
    [No Abstract]   [Full Text] [Related]  

  • 12. [Morphological aspects of immunity during the growth of transplanted syngeneic tumors (author's transl)].
    Plavsić B; Jurin M
    Lijec Vjesn; 1979 Jul; 101(7):396-400. PubMed ID: 583440
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological reconstitution of nude mice transplanted with human malignant tumours.
    Jacobsen GK; Povlsen CO; Rygaard J
    Tokai J Exp Clin Med; 1983 Dec; 8(5-6):513-27. PubMed ID: 6681344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further observations concerning effects of antilymphocyte serum on tumor growth: with special reference to allogeneic inhibition.
    Fisher B; Soliman O; Fisher ER
    Cancer Res; 1970 Jul; 30(7):2035-42. PubMed ID: 4917210
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of heterologous antilymphocyte serum on the formation of H-2 antibody and the induction of allograft immunity.
    Monaco AP; Franco DJ
    Transplant Proc; 1969 Mar; 1(1):474-8. PubMed ID: 4944263
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum.
    Monaco AP; Wood ML
    Transplant Proc; 1970 Dec; 2(4):489-96. PubMed ID: 4939696
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of the mechanism of allograft rejection and cell-mediated immunity. I. Accelerated rejection of tumour allografts without augmented cytotoxicity in the spleen cells.
    Nanishi F; Nomoto K; Taniguchi K; Kubo C
    Immunology; 1980 May; 40(1):67-76. PubMed ID: 7419243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some aspects of the cellular and humoral immune response to tumour antigens.
    Hellström KE; Hellström I
    Triangle; 1972; 11(1):23-8. PubMed ID: 4624858
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of heterologous anti-mouse lymphocyte serum (ALS) in studies of tumorogenic potentials of C3H murine cells propagated in vitro.
    Radzikowski C; Kieler J
    Arch Immunol Ther Exp (Warsz); 1972; 20(4):473-84. PubMed ID: 5078889
    [No Abstract]   [Full Text] [Related]  

  • 20. A contribution to biology of Grawitz's kidney tumor: heterotransplanatation.
    Uhlír K; Rovný F; Strmiska M; Cerný E; Navrátilová A
    Invest Urol; 1974 Jul; 12(1):23-6. PubMed ID: 4835486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.